135 related articles for article (PubMed ID: 34321311)
21. Diagnoses during the First Three Years of Life for Children with Prenatal Opioid Exposure and Neonatal Abstinence Syndrome Using a Large Maternal Infant Data Hub.
Arter S; Lambert J; Brokman A; Fall N
J Pediatr Nurs; 2021; 61():34-39. PubMed ID: 33743318
[TBL] [Abstract][Full Text] [Related]
22. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
Hussaini KS; Garcia Saavedra LF
Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
[TBL] [Abstract][Full Text] [Related]
23. Assessing the Burden of Neonatal Abstinence Syndrome: Validation of ICD-9-CM Data, Florida, 2010-2011.
Phillips-Bell GS; Holicky A; Lind JN; Sappenfield WM; Hudak ML; Petersen E; Anjorhin S; Watkins SM; Creanga AA; Correia JA
J Public Health Manag Pract; 2020; 26(1):E1-E8. PubMed ID: 31765350
[TBL] [Abstract][Full Text] [Related]
24. Assessing the relationship between neonatal abstinence syndrome and birth defects in Delaware.
Hussaini KS; Drummond D; E Bartoshesky L; Acheson A; Stomieroski K; A Paul D; Kirby RS
Birth Defects Res; 2021 Jan; 113(2):144-151. PubMed ID: 32996723
[TBL] [Abstract][Full Text] [Related]
25. Subclinical and Overt Newborn Opioid Exposure: Prevalence and First-Year Healthcare Utilization.
Percy Z; Brokamp C; McAllister JM; Ryan P; Wexelblatt SL; Hall ES
J Pediatr; 2020 Jul; 222():52-58.e1. PubMed ID: 32423682
[TBL] [Abstract][Full Text] [Related]
26. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada.
Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R
PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382
[TBL] [Abstract][Full Text] [Related]
27. Trends in Opioid-related Inpatient Stays Shifted After the US Transitioned to ICD-10-CM Diagnosis Coding in 2015.
Heslin KC; Owens PL; Karaca Z; Barrett ML; Moore BJ; Elixhauser A
Med Care; 2017 Nov; 55(11):918-923. PubMed ID: 28930890
[TBL] [Abstract][Full Text] [Related]
28. A case-control study comparing rates and diagnoses of hospital readmission in infants affected by neonatal abstinence syndrome.
Salt E; Wiggins A; Pick A; Bada H; Howard C; Currie M; Rayens MK
J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2162820. PubMed ID: 36597833
[TBL] [Abstract][Full Text] [Related]
29. Using population data to examine the prevalence and correlates of neonatal abstinence syndrome.
Burns L; Mattick RP
Drug Alcohol Rev; 2007 Sep; 26(5):487-92. PubMed ID: 17701511
[TBL] [Abstract][Full Text] [Related]
30. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality.
Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA
JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175
[TBL] [Abstract][Full Text] [Related]
31. Maternal prepregnancy surgery and risk of neonatal abstinence syndrome in future newborns: a longitudinal cohort study.
Auger N; Low N; Carrier FM; Ayoub A; Luu TM
CMAJ; 2019 Jul; 191(28):E779-E786. PubMed ID: 31308006
[TBL] [Abstract][Full Text] [Related]
32. Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
Ma J; Sahasranaman V; Kirby RS; Boaz T
J Perinatol; 2020 Oct; 40(10):1497-1505. PubMed ID: 32753708
[TBL] [Abstract][Full Text] [Related]
33. Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018.
Kelty EA; Cumming CN; Preen DB
Pharmacotherapy; 2022 May; 42(5):405-410. PubMed ID: 35342965
[TBL] [Abstract][Full Text] [Related]
34. Leveraging Existing Birth Defects Surveillance Infrastructure to Build Neonatal Abstinence Syndrome Surveillance Systems - Illinois, New Mexico, and Vermont, 2015-2016.
Lind JN; Ailes EC; Alter CC; Fornoff JE; Brozicevic P; Garcia Saavedra LF; Tomedi LE; Gambatese M; Carroll B; Orantes L; Martin B; Horne AA; Reefhuis J
MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(7):177-180. PubMed ID: 30789880
[TBL] [Abstract][Full Text] [Related]
35. Identification of Prenatal Opioid Exposure Within Health Administrative Databases.
Camden A; Ray JG; To T; Gomes T; Bai L; Guttmann A
Pediatrics; 2021 Jan; 147(1):. PubMed ID: 33376211
[TBL] [Abstract][Full Text] [Related]
36. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.
Patrick SW; Davis MM; Lehmann CU; Cooper WO
J Perinatol; 2015 Aug; 35(8):650-5. PubMed ID: 25927272
[TBL] [Abstract][Full Text] [Related]
37. Identifying patients with opioid use disorder using International Classification of Diseases (ICD) codes: Challenges and opportunities.
Osterhage KP; Hser YI; Mooney LJ; Sherman S; Saxon AJ; Ledgerwood M; Holtzer CC; Gehring MA; Clingan SE; Curtis ME; Baldwin LM
Addiction; 2024 Jan; 119(1):160-168. PubMed ID: 37715369
[TBL] [Abstract][Full Text] [Related]
38. Cigarette smoking in opioid-dependent pregnant women: neonatal and maternal outcomes.
Jones HE; Heil SH; Tuten M; Chisolm MS; Foster JM; O'Grady KE; Kaltenbach K
Drug Alcohol Depend; 2013 Aug; 131(3):271-7. PubMed ID: 23279924
[TBL] [Abstract][Full Text] [Related]
39. Using natural language processing to identify opioid use disorder in electronic health record data.
Singleton J; Li C; Akpunonu PD; Abner EL; Kucharska-Newton AM
Int J Med Inform; 2023 Feb; 170():104963. PubMed ID: 36521420
[TBL] [Abstract][Full Text] [Related]
40. Maternal opioid use disorder and infant mortality in Wisconsin, United States, 2010-2018.
Mallinson DC; Kuo HD; Kirby RS; Wang Y; Berger LM; Ehrenthal DB
Prev Med; 2024 Apr; 181():107914. PubMed ID: 38408650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
